Gayer Charles K Insider Trades

Insider Trading History

Track insider trading activity for Gayer Charles K. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
President And CCO
Holding Value $8.96M 952,583 shares
Last Trade
Dec 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$565k 74,233 shares
$7.61
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
President And CCO
Holding Value $164k 17,409 shares
Last Trade
Dec 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$565k 74,233 shares
$7.61
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
President And CCO
Holding Value $8.27M 878,350 shares
Last Trade
Dec 19, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$85k 11,477 shares
$7.41
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
President And CCO
Holding Value $9.29M 986,950 shares
Last Trade
Dec 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4M 1,457,950 shares
$7.13
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
President And CCO
Holding Value $3.94M 418,827 shares
Last Trade
Dec 12, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.9k 8,181 shares
$7.57
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $4.01M 426,007 shares
Last Trade
Dec 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 260,950 shares
$7.39
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $3.99M 423,546 shares
Last Trade
Dec 19, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.2k 2,461 shares
$7.39
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.82M 300,057 shares
Last Trade
Dec 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$62.1k 8,251 shares
$7.53
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.89M 307,533 shares
Last Trade
May 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$164k 30,000 shares
$5.47
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.58M 274,533 shares
Last Trade
Dec 19, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15k 2,482 shares
$6.05
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.61M 277,015 shares
Last Trade
Dec 14, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.6k 5,840 shares
$6.43
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.66M 282,855 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 158,500 shares
$6.43
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $1.99M 211,610 shares
Last Trade
Dec 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.5k 6,100 shares
$10.90
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.46M 261,556 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.3M 289,000 shares
$11.43
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Commercial Officer
Holding Value $2.04M 216,556 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$914k 80,000 shares
$11.43
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Vice President And CCO
Holding Value $0 0 shares
Last Trade
Dec 17, 2020 Sale
$869k 106,000 shares
$8.20
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Vice President And CCO
Holding Value $1.79M 190,000 shares
Last Trade
Dec 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 190,000 shares
$8.31
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Vice President And CCO
Holding Value $0 0 shares
Last Trade
Dec 20, 2019 Sale
$209k 65,000 shares
$3.21
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Vice President And CCO
Holding Value $0 0 shares
Last Trade
Dec 20, 2018 Sale
$194k 27,500 shares
$7.06
$9.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Vice President And CCO
Holding Value $0 0 shares
Last Trade
Feb 27, 2018 Sale
$242k 50,000 shares
$4.83
$9.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up